Astera Labs Inc (ALAB) concluded trading on Thursday at a closing price of $99.60, with 5.21 million shares of worth about $518.63 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 52.20% during that period and on November 28, 2024 the price saw a loss of about -5.57%. Currently the company’s common shares owned by public are about 155.47M shares, out of which, 114.91M shares are available for trading.
Stock saw a price change of 2.24% in past 5 days and over the past one month there was a price change of 34.47%. Over the period of past 52 weeks, stock dropped to lowest price of $36.22 but also hit the highest price of $113.85 during that period. The average intraday trading volume for Astera Labs Inc shares is 4.67 million. The stock is currently trading 7.71% above its 20-day simple moving average (SMA20), while that difference is up 36.21% for SMA50 and it goes to 57.42% higher than SMA200.
Astera Labs Inc (NASDAQ: ALAB) currently have 155.47M outstanding shares and institutions hold larger chunk of about 46.16% of that.
The stock has a current market capitalization of $14.92B. It has posted earnings per share of -$0.60 in the same period. It has Quick Ratio of 10.46 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALAB, volatility over the week remained 7.71% while standing at 7.43% over the month.
Stock’s fiscal year EPS is expected to rise by 701.41% while it is estimated to increase by 61.89% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Citigroup on November 18, 2024 offering a Buy rating for the stock and assigned a target price of $120 to it. Coverage by Morgan Stanley stated Astera Labs Inc (ALAB) stock as an Overweight in their note to investors on September 04, 2024, suggesting a price target of $55 for the stock. On April 16, 2024, Evercore ISI Initiated their recommendations, while on April 15, 2024, Stifel Initiated their ratings for the stock with a price target of $81. Stock get a Buy rating from ROTH MKM on April 15, 2024.
